IFG
TNYA icon

Independent Financial Group’s Tenaya Therapeutics TNYA Stock Holding History

Independent Financial Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,000
Closed -$40.5K – 1484
2025
Q3 		$40.5K Hold
25,000
– – ﹤0.01% 1349
2025
Q2 		$15.3K Hold
25,000
– – ﹤0.01% 1283
2025
Q1 		$14.3K Hold
25,000
– – ﹤0.01% 1168
2024
Q4 		$35.8K Buy
+25,000
New +$56K ﹤0.01% 1148

Other funds holding TNYA

CG
Column Group San Francisco, California $88.1M AUM 148.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Independent Financial Group's TNYA Position: Q4 2025 in Review

Independent Financial Group sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 25,000 shares — an estimated $40.5K sold.

Independent Financial Group first reported a position in TNYA in Q4 2024 and held it in 4 quarters. The position peaked at $40.5K in Q3 2025. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Independent Financial Group reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Independent Financial Group sold 25,000 Tenaya Therapeutics shares in Q4 2025, an estimated $40.5K.
  • Independent Financial Group first reported a position in Tenaya Therapeutics in Q4 2024 and held it in 4 quarters.
  • Independent Financial Group's Tenaya Therapeutics position peaked at $40.5K in Q3 2025.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Independent Financial Group's 13F filing for Q4 2025, filed 15 May 2026.